Login / Signup

Rezum therapy for patients with large prostates (≥ 80 g): initial clinical experience and postoperative outcomes.

Evan B GardenDevki ShuklaKrishna T RavivarapuSteven A KaplanAvinash K ReddyAlexander C SmallMichael A Palese
Published in: World journal of urology (2021)
In select LP patients, Rezum provided short-term symptomatic relief and improved voiding function comparable to SP patients. Postoperatively, though alpha-blocker usage decreased significantly, use of other medications did not change, and nearly two-thirds of patients still needed alpha-blockade. Further efforts should explore the possibility of expanding Rezum's inclusion criteria.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • type diabetes
  • metabolic syndrome
  • insulin resistance
  • angiotensin ii
  • patient reported